Authorship Policy
MAIN MANUSCRIPT
We expect to prepare a main manuscript describing the general data and main results dealing with differences in practice in participating countries and one or two other manuscripts describing details in prescriptions of analgesics and sedatives as well as in pain assessing practices. The order of contributing authors in the papers will depend on their contribution to the study assessed by the number of included patients and the proportion of participating units in the country. A total score will be obtained by giving an 85% weight to the number of patients and a 15% weight to the proportion of participating units compared to the total number of NICU units of the country.
For the first paper the expected order of contributing authors will be:
R Carbajal, 1st rank of national investigator, 2nd rank of national investigator, …last rank of national investigator, two members of the steering committee NeoOpioid consortium , E Courtois, M Erikson on behalf of the EUROPAIN STUDY GROUP.
For the second paper the expected order of contributing authors
M Erikson, 1st rank of national investigator, 2nd rank of national investigator, …last rank of national investigator, two members of the steering committee NeoOpioid consortium, E Courtois, R Carbajal on behalf of the EUROPAIN STUDY GROUP.
Members of the steering committee NeoOpioid consortium that are potential authors:
KJS Anand, H Lagercrantz, L Bergqvist
The authors included in the Europain study group will be presented as follows: “The following hospitals and investigator participated in the EUROPAIN SURVEY, with study sites listed according to the number of infants they enrolled:…”
NATIONAL PAPERS
Once the main paper will be published, national data will be sent to national principal investigators so as they can publish their local data in national scientific journals.
We will encourage the communication (congress or papers) at the national level with national results.